FACE IPF
HEAD ON
and modify disease progression by slowing lung function decline
PPF in CTD-ILD: How do we keep patients on treatment with nintedanib?
05/06/2024 | Author: Boehringer Ingelheim
Document ID: PC-AE-102133 | Expiry Date: 05/08/2026
RELATED CONTENT
03:37
PPF in CTD-ILD: How does nintedanib fit in with background treatments for underlying CTDs?
03:43
PPF in CTD-ILD: Treatment of patients with PPF and CTD-ILD
04:12
PPF in CTD-ILD: How do we monitor patients with CTD-ILD?
03:39